Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-22-017102

Options or other derivatives

  • Chief Medical Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FISHMAN ROBERT S · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,000 60,000 D
Loading xslF345X03/doc1.xml…